Nvidia has acquired minority stakes in nine European startups, including four in France and five in the UK. The chipmaker did not disclose the specific investment amounts or valuations for these deals.
The portfolio companies operate across healthcare, robotics, drug discovery, enterprise planning, and quantum computing. Nvidia also pledged $250 million in computing resources for UK AI safety research.
The startups include Genesis AI, which raised $105 million in a seed round, and Pigment, a unicorn that secured $145 million in Series D funding. Doctolib, which serves 100 million patients, is also among the group.
Other investments include Entalpic, which raised €8.5 million, and Boltz, which secured $28 million at a $125 million valuation. Riverlane, focused on quantum error correction, has raised roughly $120 million to date.
The list is completed by Foresight, which raised $25 million in Series A funding, Hiverge, which secured $5 million in seed capital, and Prima Mente, a recipient of a $1 million prize.
